AROVELLA THERAPEUTICS financial statements, including revenue, expenses, and profit
The total revenue of E4NA for the last semiannual is 81.28 k EUR, and it's 1436.70% higher compared to the previous semiannual. The net income of H1 25 is -873.47 k EUR.